Yan Sun

Zhejiang Porton Pharmaceutical Co., Ltd. engages in the provision of technical services for innovative medicines, research and development of chemical raw materials, and production and sale of pharmaceutical intermediates and chemical products. The company was founded on November 18, 2009 and is headquartered in China.

Zhejiang Porton Pharmaceutical Co., Ltd. engages in the provision of technical services for innovative medicines, research and development of chemical raw materials, and production and sale of pharmaceutical intermediates and chemical products. The company was founded on November 18, 2009 and is headquartered in China.

Zhejiang Porton Pharmaceutical Co., Ltd. engages in the provision of technical services for innovative medicines, research and development of chemical raw materials, and production and sale of pharmaceutical intermediates and chemical products. The company was founded on November 18, 2009 and is headquartered in China.

Zhejiang Porton Pharmaceutical Co., Ltd. engages in the provision of technical services for innovative medicines, research and development of chemical raw materials, and production and sale of pharmaceutical intermediates and chemical products. The company was founded on November 18, 2009 and is headquartered in China.

Zhejiang Porton Pharmaceutical Co., Ltd. engages in the provision of technical services for innovative medicines, research and development of chemical raw materials, and production and sale of pharmaceutical intermediates and chemical products. The company was founded on November 18, 2009 and is headquartered in China.

Zhejiang Liaoyuan Pharmaceutical Co., Ltd. engages in the manufacturing of APIs and intermediates for anticoagulants, antidepressants, and cardiovascular drugs. Its products include Clopidogrel, Ticlopidine Hydrochloride, Mirtazapine, 2-thiophene ethanol, 2-thiophene ethylamine, and other related pharmaceutical products. The company was founded on March 26, 1994 and is headquartered in Linhai, China.

Zhejiang Liaoyuan Pharmaceutical Co., Ltd. engages in the manufacturing of APIs and intermediates for anticoagulants, antidepressants, and cardiovascular drugs. Its products include Clopidogrel, Ticlopidine Hydrochloride, Mirtazapine, 2-thiophene ethanol, 2-thiophene ethylamine, and other related pharmaceutical products. The company was founded on March 26, 1994 and is headquartered in Linhai, China.

Zhejiang Porton Pharmaceutical Co., Ltd. engages in the provision of technical services for innovative medicines, research and development of chemical raw materials, and production and sale of pharmaceutical intermediates and chemical products. The company was founded on November 18, 2009 and is headquartered in China.

Zhejiang Liaoyuan Pharmaceutical Co., Ltd. engages in the manufacturing of APIs and intermediates for anticoagulants, antidepressants, and cardiovascular drugs. Its products include Clopidogrel, Ticlopidine Hydrochloride, Mirtazapine, 2-thiophene ethanol, 2-thiophene ethylamine, and other related pharmaceutical products. The company was founded on March 26, 1994 and is headquartered in Linhai, China.

Zhejiang Liaoyuan Pharmaceutical Co., Ltd. engages in the manufacturing of APIs and intermediates for anticoagulants, antidepressants, and cardiovascular drugs. Its products include Clopidogrel, Ticlopidine Hydrochloride, Mirtazapine, 2-thiophene ethanol, 2-thiophene ethylamine, and other related pharmaceutical products. The company was founded on March 26, 1994 and is headquartered in Linhai, China.

Zhejiang Liaoyuan Pharmaceutical Co., Ltd. engages in the manufacturing of APIs and intermediates for anticoagulants, antidepressants, and cardiovascular drugs. Its products include Clopidogrel, Ticlopidine Hydrochloride, Mirtazapine, 2-thiophene ethanol, 2-thiophene ethylamine, and other related pharmaceutical products. The company was founded on March 26, 1994 and is headquartered in Linhai, China.

Zhejiang Liaoyuan Pharmaceutical Co., Ltd. engages in the manufacturing of APIs and intermediates for anticoagulants, antidepressants, and cardiovascular drugs. Its products include Clopidogrel, Ticlopidine Hydrochloride, Mirtazapine, 2-thiophene ethanol, 2-thiophene ethylamine, and other related pharmaceutical products. The company was founded on March 26, 1994 and is headquartered in Linhai, China.